Metraipolis › archive › dc_16faab04809d

In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers — Europe PMC PMID:40994521

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40994521
DOI
10.1039/d5na00361j
License (as archived)
solo-consultazione
Archived
2026-11-10T04:03:28.695Z
SHA-256 of the archived text
3bf86fbeb8dc2e2dccc73ec88b0b5e9c7a1c8fbfac459f70152e8bf5e9d35935
Stable URL of this page
https://metraipolis.com/documento/dc_16faab04809d

How to cite

In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers — Europe PMC PMID:40994521 — Europe PMC (en), https://europepmc.org/article/MED/40994521 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_16faab04809d (Metraipolis archive dc_16faab04809d, sha256 3bf86fbeb8dc2e2dccc73ec88b0b5e9c7a1c8fbfac459f70152e8bf5e9d35935)
BibTeX
@misc{dc16faab04809d,
  title = {In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers — Europe PMC PMID:40994521},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40994521},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_16faab04809d; sha256 3bf86fbeb8dc2e2dccc73ec88b0b5e9c7a1c8fbfac459f70152e8bf5e9d35935},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40994521. Agents can read the archived copy with the MCP tool read_document.